Company page

Surrozen, Inc.

Surrozen, Inc. is a public biotechnology company traded under the ticker SRZN in the American market. The company has a market capitalization of approximately $304.3 million. Surrozen focuses on developing innovative therapeutics to address unmet medical needs.